Tag: Cancer
-
Exploring an Iron-based Alternative to Chemotherapy
Iron nanoparticles could be one day used to attack cancer cells, according to a recent Northwestern Medicine study.
-
New Machine-learning Method to Identify Chromatin Loops
A machine-learning program called Peakachu can reveal previously unknown chromatin loops, according to a Northwestern Medicine study published in Nature Communications.
-
Analyzing Plasma Can Classify Brain Tumors
Measuring epigenetic signatures in blood plasma could help classify brain tumors, according to a study published in Nature Medicine.
-
Protein May Improve Immunotherapy for Medulloblastoma
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
-
Mitochondrial Metabolism Shows Promise as Target for Cancer Therapy
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
-
New Inhibitor Starves HIV
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
-
New Therapy Extends Breast Cancer Survival Rate, Prevents Reoccurrence
A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.
-
COVID-19 Complicates Cancer Treatment
Cancer patients with other comorbidities have a higher risk of dying from complications due to COVID-19, and should discuss the risks and benefits of continuing cancer treatment with their physician, according to a recent study.
-
Novel Drug Improves Survival in Advanced Prostate Cancer
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
-
Chimeric Toxin Slows Cancer Growth
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
